亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購(gòu)物車
企業(yè)會(huì)員第1年

無(wú)錫同創(chuàng)生物科技有限公司  

辣根過(guò)氧化物酶,5-溴-4氯-3吲哚-神經(jīng)氨酸,吡咯酯等

搜索
新聞中心
  • 暫無(wú)新聞
產(chǎn)品分類
  • 暫無(wú)分類
聯(lián)系方式
  • 聯(lián)系人:張倩
  • 電話:13655185676
  • 郵件:wuxitongchuang@yahoo.cn
  • 傳真:0510-85899582
  • QQ:1760363918
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無(wú)鏈接
首頁(yè) > 供應(yīng)產(chǎn)品 > 同創(chuàng)主推產(chǎn)品
同創(chuàng)主推產(chǎn)品
單價(jià) 面議對(duì)比
詢價(jià) 暫無(wú)
發(fā)貨 江蘇無(wú)錫市付款后3天內(nèi)
品牌 同創(chuàng)生物
型號(hào) 4730-54-5
規(guī)格 98.0
過(guò)期 長(zhǎng)期有效
更新 2024-01-10 11:53
 
詳細(xì)信息

.英文名稱:1,4,7-Triazacyclononane

英文別名:Octahydro-1H-1,4,7-triazonine

CAS:4730-54-5

純度 / 方法:>98.0%(GC)

分子式 / 分子量:C6H15N3=129.20
技術(shù)參數(shù)
熔點(diǎn) 45℃
沸點(diǎn) 113℃/7mmHg
©2025 無(wú)錫同創(chuàng)生物科技有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問(wèn)量:36666  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |